Press Releases

SAN DIEGO, Nov. 8, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Company presented data from the Toca 6 Phase

SAN DIEGO and KALAMAZOO, Mich., Nov. 8, 2019 /PRNewswire/ -- Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases, today announced data from its recently completed 12-month Phase 2b

SAN FRANCISCO, Nov. 8, 2019 /PRNewswire/ -- QB3 is proud to announce the 2019 cohort of the annual QB3 Biotech/Biopharma Pitch Summit, a group of early-stage companies chosen for their innovative technologies and potential market impact.This is the third year of the competition, which is open to life science startups based in California

LONDON, Nov. 8, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in primary and revision hip arthroplasty. Compared with traditional solutions, dual mobility implants have a small diameter femoral head that locks into a larger polyethylene insert - increasing

JACKSON, Miss., Nov. 8, 2019 /PRNewswire/ -- Allwell from Magnolia Health announces a partnership with the National Council on Aging (NCOA) to help prevent falls among Medicare Advantage beneficiariesFalls are a leading cause of injury for people aged 65 and older and can threaten their safety and independence, as well as generate great economic and personal

CHICAGO, Nov. 8, 2019 /PRNewswire/ -- In an era of shifting consumer expectations, a healthcare system often described as dysfunctional and high levels of physician burnout, it's particularly noteworthy to report the uniformly excellent satisfaction ratings concierge medicine receives from doctors and patients alike. According to Specialdocs Consultants'

BOSTON, Nov. 8, 2019 /PRNewswire/ -- (NASDAQ: EXAS) – A new study of 443 patients by Exact Sciences Corp. and its collaborators demonstrated 80% sensitivity at 90% specificity with a novel combination of six blood-based biomarkers for the most common type of liver cancer, hepatocellular carcinoma (HCC)i. The study also showed 71% sensiti

PETERBOROUGH, N.H., Nov. 8, 2019 /PRNewswire/ -- SoClean, the creator of SoClean 2, announced today that it has been named by Deloitte as one of America's fastest growing technology companies for the

NEWPORT BEACH, Calif., Nov. 8, 2019 /PRNewswire/ -- Neurologics, an innovative company that applies proprietary technology to optimize and permanently improve brain function, announced today that Colonel (retired) Dallas C. Hack, MD, MPH has joined the company as Chairman of the Scientific Advisory Board. "We are so honored to h

STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma Treatment Solution (OTS) with a module also for spine surgery.– The conclusion after a number of performed surgeries is that our surgical system provides dis